National Jewish Health:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:National Jewish Health - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9300
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
National Jewish Health (NJH), formerly National Jewish Medical and Research Center is a healthcare service provider that offers treatment for pulmonary, cardiac, immune and related disorders. The center conducts programs in the therapeutic areas of allergy, asthma, bronchicardiology, bronchiectasis, idiopathic pulmonary fibrosis, clinical immunology, COPD, environmental and occupational health, gastroenterology, rheumatology, sleep, interstitial lung disease, nephrology, oncology, pulmonology and respiratory, among others. It offers academic training, professional education, and patient education for physicians, scientists, healthcare professionals, and patients. The center has operations in New York, California, Washington, D.C., Florida and Illinois. NJH is headquartered in Denver, Colorado, the US.

National Jewish Health – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
National Jewish Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
National Jewish Health, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
National Jewish Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
National Jewish Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
National Jewish Health, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
National Jewish Health, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
National Jewish Health, Saint Joseph’s Hospital and SCL Health Announce to Form Joint Venture 10
National Jewish Health Forms Joint Venture With Icahn School of Medicine at Mount Sinai 11
Licensing Agreements 12
Aeolus Pharma Enters into Licensing Agreement with National Jewish Health 12
Oncomatrix Enters Into Licensing Agreement With National Jewish Health For Cystatin-C Intellectual Property 13
National Jewish Health – Key Competitors 14
National Jewish Health – Key Employees 15
National Jewish Health – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Corporate Communications 19
Jan 25, 2018: Jefferson Health and National Jewish Health Announce Jesse Roman, MD, as CEO of the Jane & Leonard Korman Respiratory Institute 19
Government and Public Interest 20
Nov 14, 2017: $8.5M Grant Awarded to Improve Asthma Care with the Navajo Nation 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
National Jewish Health, Pharmaceuticals & Healthcare, Key Facts 2
National Jewish Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
National Jewish Health, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
National Jewish Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
National Jewish Health, Deals By Therapy Area, 2012 to YTD 2018 8
National Jewish Health, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
National Jewish Health, Saint Joseph's Hospital and SCL Health Announce to Form Joint Venture 10
National Jewish Health Forms Joint Venture With Icahn School of Medicine at Mount Sinai 11
Aeolus Pharma Enters into Licensing Agreement with National Jewish Health 12
Oncomatrix Enters Into Licensing Agreement With National Jewish Health For Cystatin-C Intellectual Property 13
National Jewish Health, Key Competitors 14
National Jewish Health, Key Employees 15
National Jewish Health, Key Employees (cont..) 17
National Jewish Health, Other Locations 18

List of Figures
National Jewish Health, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
National Jewish Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
National Jewish Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
National Jewish Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
National Jewish Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
National Jewish Health, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
National Jewish Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
National Jewish Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[National Jewish Health:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Black Hills Power Inc:電力:M&Aディール及び事業提携情報
    Summary Black Hills Power Inc (Black Hills), a subsidiary of Black Hills Corp, is a power company that generates, transmits and distributes electricity. The company generates electricity through coal, gas, and oil resources. Its services include electricity and natural gas transmission and distribut …
  • Ggp Inc
    Ggp Inc - Strategy, SWOT and Corporate Finance Report Summary Ggp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Tepha Inc:企業の製品パイプライン分析
    Summary Tepha Inc (Tepha) is a medical device firm that develops and commercializes biomaterial technology products. The firm offers products such as absorbable monofilament suture, absorbable monofilament mesh, composite mesh and absorbable surgical film. It also provides platforms including absorb …
  • Groupama Assurances Mutuelles:企業の戦略・SWOT・財務分析
    Groupama Assurances Mutuelles - Strategy, SWOT and Corporate Finance Report Summary Groupama Assurances Mutuelles - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Ewopharma AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Ewopharma AG (Ewopharma) is a pharmaceutical company that provides registration and marketing of pharmaceuticals and consumer health products. The company provides services such as market evaluation, marketing services, regulatory affairs, licensing, pharmacovigilance, and others. It offers …
  • Cohera Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Cohera Medical Inc (Cohera) is a medical device company that designs and develops surgical adhesives and sealants. The company provides products such as TissuGlu surgical adhesive, Sylys surgical sealant, and others. Its TissuGlu surgical adhesive is biocompatible for internal use, and forms …
  • National Bank of Canada:企業の戦略・SWOT・財務分析
    National Bank of Canada - Strategy, SWOT and Corporate Finance Report Summary National Bank of Canada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Genfit SA (GNFT):企業の財務・戦略的SWOT分析
    Summary Genfit SA (Genfit) is a biopharmaceutical company that develops therapeutic and diagnostic solutions for metabolic and inflammatory diseases in liver and gastroenterology diseases. The company’s pipeline products include GFT505, NASH, TGFTX1 and Nitazoxanide (NTZ). Its TGFTX1 is a research p …
  • Euronet Worldwide, Inc.:企業の戦略・SWOT・財務分析
    Euronet Worldwide, Inc. - Strategy, SWOT and Corporate Finance Report Summary Euronet Worldwide, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • South Broward Hospital District:企業の戦略的SWOT分析
    South Broward Hospital District - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Coty Inc.:企業の戦略・SWOT・財務情報
    Coty Inc. - Strategy, SWOT and Corporate Finance Report Summary Coty Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Crescendo Biologics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Crescendo Biologics Ltd (Crescendo) is a biopharmaceutical company that manufactures antibody therapeutics based on a transgenic mouse platform. The company’s pipeline includes humabody programs targeting oncology. It practises in the antibody discoveries and development, which include CAT, …
  • Altium Ltd:企業の戦略・SWOT・財務情報
    Altium Ltd - Strategy, SWOT and Corporate Finance Report Summary Altium Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Selecta Biosciences Inc (SELB):企業の財務・戦略的SWOT分析
    Summary Selecta Biosciences Inc (Selecta Biosciences) is a biopharmaceutical company that develops immunotherapies and vaccines for the treatment and prevention of human diseases. The company’s pipeline products include SEL-212, SEL-403, SEL-302 and SEL-302. It utilizes synthetic vaccine particle (S …
  • Unipetrol, a.s. (UNIPE):石油・ガス:M&Aディール及び事業提携情報
    Summary Unipetrol AS (Unipetrol), a subsidiary of Polski Koncern Naftowy Orlen SA, is refinery and petrochemical company. The company produces and sells petroleum products, petrochemicals, plastics and specialty chemicals. Unipetrol owns and operates transport services, filling stations and carries …
  • Marenica Energy Ltd (MEY):企業の財務・戦略的SWOT分析
    Summary Marenica Energy Ltd (MEY) is a mining and mineral resource exploration and development company that acquires, identifies, develops, and explores for lead, silver, zinc, copper, uranium and gold mineral properties in Australia. The company develops and operates uranium project using conventio …
  • Hitachi Zosen Corporation (7004):企業の財務・戦略的SWOT分析
    Hitachi Zosen Corporation (7004) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Seoul National University Hospital:製薬・医療:M&Aディール及び事業提携情報
    Summary Seoul National University Hospital (SNUH) is a healthcare service provider. It operates as the representative medical center of Korea. The hospital focuses on raising the standards of nation’s healthcare system, medical education, research and patient care. It offers services such as outpati …
  • Kingdom Hotel Investments:企業の戦略・SWOT・財務分析
    Kingdom Hotel Investments - Strategy, SWOT and Corporate Finance Report Summary Kingdom Hotel Investments - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • QuadGraphics Inc (QUAD):企業の財務・戦略的SWOT分析
    QuadGraphics Inc (QUAD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆